Glycogen synthase kinase 3 (GSK3) inhibition: a potential therapeutic strategy for Alzheimer’s disease

被引：0
|
作者：
Dipanjan Karati [1 ]
Shreyasi Meur [1 ]
Souvik Roy [2 ]
Swarupananda Mukherjee [2 ]
Biplab Debnath [3 ]
Sajal Kumar Jha [4 ]
Biresh Kumar Sarkar [5 ]
Saheli Naskar [2 ]
Priya Ghosh [2 ]
机构：
[1] Techno India University,Department of Pharmaceutical Technology, School of Pharmacy
[2] NSHM Knowledge Campus,Department of Pharmaceutical Technology
[3] Kolkata - Group of Institutions,Department of Pharmaceutical Technology
[4] Bharat Technology,Department of Pharmaceutical Technology
[5] Uluberia,undefined
[6] Bengal College of Pharmaceutical Technology,undefined
[7] Central Ayurveda Research Institute,undefined
来源：
Naunyn-Schmiedeberg's Archives of Pharmacology | 2025年 / 398卷 / 3期
关键词：
GSK-3; Alzheimer’s disease; Neuroinflammation; NF-κB-mediated transcription; Axonal impairment; Neurodegeneration;
D O I：
10.1007/s00210-024-03500-1
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2319 / 2342
页数：23
相关论文
共 50 条
  • [1] Glycogen synthase kinase-3 (GSK3): A potential therapeutic target to treat neuroinflammation?
    De Sarno, Patrizia
    Axtell, Robert C.
    Raman, Chander
    Roth, Kevin A.
    Alessi, Dario R.
    Jope, Richard S.
    JOURNAL OF NEUROIMMUNOLOGY, 2008, 203 (02) : 235 - 235
  • [2] Glycogen synthase kinase-3 (GSK3) in psychiatric diseases and therapeutic interventions
    Jope, Richard S.
    Roh, Myoung-Suin
    CURRENT DRUG TARGETS, 2006, 7 (11) : 1421 - 1434
  • [3] PROTAC-Induced Glycogen Synthase Kinase 3ß Degradation as a Potential Therapeutic Strategy for Alzheimer's Disease
    Guardigni, Melissa
    Pruccoli, Letizia
    Santini, Alan
    De Simone, Angela
    Bersani, Matteo
    Spyrakis, Francesca
    Frabetti, Flavia
    Uliassi, Elisa
    Andrisano, Vincenza
    Pagliarani, Barbara
    Fernandez-Gomez, Paula
    Palomo, Valle
    Bolognesi, Maria Laura
    Tarozzi, Andrea
    Milelli, Andrea
    ACS CHEMICAL NEUROSCIENCE, 2023, 14 (11): : 1963 - 1970
  • [4] Glycogen synthase kinase-3β (GSK3β) expression in a mouse model of Alzheimer's disease: A light and electron microscopy study
    Gandy, Johanna C.
    Melendez-Ferro, Miguel
    Bijur, Gautam N.
    Van Leuven, Fred
    Roche, Joy K.
    Lechat, Benoit
    Devijver, Herman
    Demedts, David
    Perez-Costas, Emma
    Roberts, Rosalinda C.
    SYNAPSE, 2013, 67 (06) : 313 - 327
  • [5] Glycogen synthase kinase 3β (GSK3β) in tumorigenesis and cancer chemotherapy
    Luo, Jia
    CANCER LETTERS, 2009, 273 (02) : 194 - 200
  • [6] Glycogen Synthase Kinase 3 (GSK3): Its Role and Inhibitors
    Wadhwa, Pankaj
    Jain, Priti
    Jadhav, Hemant R.
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2020, 20 (17) : 1522 - 1534
  • [7] Glycogen synthase kinase-3 (GSK-3): A kinase with exceptional therapeutic potential
    Benbow, JW
    Helal, CJ
    Kung, DW
    Wager, TT
    ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 40, 2005, 40 : 135 - 147
  • [8] Glycogen Synthase Kinase-3 (GSK-3) Inhibitors for the Treatment of Alzheimer's Disease
    Medina, Miguel
    Avila, Jesus
    CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (25) : 2790 - 2798
  • [9] Glycogen synthase kinase 3β and Alzheimer's disease:: pathophysiological and therapeutic significance
    Balaraman, Y.
    Limaye, A. R.
    Levey, A. I.
    Srinivasan, S.
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2006, 63 (11) : 1226 - 1235
  • [10] Glycogen synthase kinase 3β and Alzheimer’s disease: pathophysiological and therapeutic significance
    Y. Balaraman
    A. R. Limaye
    A. I. Levey
    S. Srinivasan
    Cellular and Molecular Life Sciences CMLS, 2006, 63 : 1226 - 1235
12345